CRNX
#991
Crinetics Pharmaceuticals, Inc. - Common Stock
84.8 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.01%
Monthly Change
+1.14%
6 month change
+109.71%
Year Change
+106.45%
Previous Close
84.8 4
Open
84.8 5
Low
84.8 5
High
84.8 5
Volume
117
Financials
- Market Capitalization 9 B
- Employee 594
- Founded 2008
- CEO N/A
- Website www.crinetics.com
- Headquarter Delaware, United States
- FIGI BBG00BC59224
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-7.41
Price to sales ratio
91.7
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 981 |  PCVX Vaxcyte, Inc. - Common Stock | 61.16 USD | +0.11% | -1.12% | +12.22% | +44.59% | 9.10 B USD | ||
| 983 |  IMVT Immunovant, Inc. - Common Stock | 43.82 USD | -0.16% | -2.03% | +12.42% | +128.11% | 9.05 B USD | ||
| 993 |  ABVX Abivax SA - American Depositary Shares | 114.30 USD | -1.91% | -2.88% | -8.49% | +39.39% | 8.98 B USD | ||
| 998 |  IBRX ImmunityBio, Inc. - Common Stock | 8.40 USD | +1.82% | +7.01% | +20.00% | +258.97% | 8.90 B USD |
Frequently asked questions about Crinetics Pharmaceuticals, Inc.
What is the Crinetics Pharmaceuticals, Inc. stock price today?
The current price of Crinetics Pharmaceuticals, Inc. (CRNX) is 84.85. Over the past 24 hours, the stock has changed by +0.01%. Follow the CRNX chart for real-time price dynamics.
What is the stock ticker of Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. trades under the ticker CRNX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Crinetics Pharmaceuticals, Inc. stock going up?
CRNX has changed by +0.18% over the last week, +1.14% over the last month, and +106.45% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Crinetics Pharmaceuticals, Inc.?
Crinetics Pharmaceuticals, Inc. currently has a market capitalization of 9 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Crinetics Pharmaceuticals, Inc. earnings last quarter?
Last quarter, Crinetics Pharmaceuticals, Inc. reported earnings of -1.14 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Crinetics Pharmaceuticals, Inc. revenue for the last quarter?
Crinetics Pharmaceuticals, Inc. reported quarterly revenue of 25.12 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Crinetics Pharmaceuticals, Inc. net income for the last quarter?
Crinetics Pharmaceuticals, Inc. reported net income of -120.86 M for the last quarter. The previous quarter showed -127.84 M, which means net income changed by +5.47%.
How many employees does Crinetics Pharmaceuticals, Inc. have?
As of the latest available data, Crinetics Pharmaceuticals, Inc. has 594 employees. Workforce size can provide additional context about the company's scale and operations.
What is Crinetics Pharmaceuticals, Inc. EBITDA?
Crinetics Pharmaceuticals, Inc. EBITDA is -134.48 M, and its EBITDA margin is -535.4%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Crinetics Pharmaceuticals, Inc. stock?
You can buy Crinetics Pharmaceuticals, Inc. (CRNX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Crinetics Pharmaceuticals, Inc. stock?
Investing in Crinetics Pharmaceuticals, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CRNX chart and related analysis on metatrader.com as part of your research.